Possible side effects and harm to health of Leborexan (Daveco)
1. Overview of Drugs
Lemborexant is a dual hypnotic -arousal regulation receptor antagonist (dual orexin receptor antagonist, DORA), which works by antagonizing the brain’s Orexin-1 and Orexin-2 receptors inhibit arousal signals, thereby helping patients fall asleep and maintain sleep. It is mainly used to treat insomnia, especially patients who have difficulty falling asleep or maintaining sleep. Compared with traditional benzodiazepine hypnotics, leborexan has certain advantages in reducing dependence and cognitive impairment, but it may still cause a variety of side effects and requires attention to physical health.
2. Common side effects and physiological effects
1.Daytime sleepiness and decreased attention
The most common side effects of leborexan are Daytime drowsiness, fatigue and decreased concentration, which are more obvious in the early stages of medication or at higher doses. Patients may experience sluggish reactions when working, driving, or operating machinery, increasing the risk of accidents. Chronic sleepiness may also affect daily life efficiency and mental state.
2.Headache, dizziness and effects on cognitive function
Some patients may develop headache, dizziness, memory loss or mild cognitive impairment after taking the drug Although most symptoms can be relieved with continued use or dose adjustment, in the elderly or patients with neurological diseases, the risk of falls and cognitive impairment may be increased.
3.Gastrointestinal reactions
Leborexan may cause digestive discomfort such as nausea, diarrhea, or constipation . Such side effects are usually mild to moderate, but long-term gastrointestinal irritation may affect appetite, nutritional intake, and weight management. Patients with weak constitutions or patients with digestive system diseases need special attention.

3. Rare but serious side effects
1.Abnormal emotional and mental status
A small number of patients may experience nightmares, anxiety, depression or mood swings These psychiatric symptoms are mostly related to changes in sleep structure and antagonism of arousal regulatory receptors. In severe cases, drug withdrawal or combined psychiatric intervention may be required.
2.Drug dependence and withdrawal reactions
Although the risk of dependence on leborexan is lower than that of benzodiazepines, long-term high-dose use may still occur Mild drug dependence or sleep rebound after drug withdrawal, manifested by worsening difficulty falling asleep and increased nighttime awakenings.
3.Risk of falls and fractures
Especially In elderly patients, drug-induced drowsiness, dizziness and cognitive decline may increase the risk of falls and fractures, seriously affecting their quality of life and physical health.
4. Long-term health effects and safety management
1.Effects on the cardiovascular system
Clinical studies have shown that leborexan has little effect on blood pressure, heart rate and QT interval, but patients with cardiovascular diseases still need to pay attention to monitoring. Long-term use requires attention to potential blood pressure fluctuations, abnormal heart rhythms, or risks of cardiovascular events.
2.Liver function and drug metabolism
Leborexan is mainly metabolized by CYP3A4. Patients with liver dysfunction may have elevated blood drug concentrations, increasing the incidence of side effects. Therefore, for people with abnormal liver function, the dose needs to be adjusted or the monitoring interval needs to be extended.
3.Individualized medication and follow-up
To reduce the risk of side effects, patients should take it under the guidance of a doctor Strictly follow the recommended dosage and time, and avoid the simultaneous use of alcohol or other central nervous system depressant drugs. Long-term medication requires regular follow-up, including sleep quality assessment, cognitive and emotional status monitoring, and liver function and blood pressure tests to ensure safety.
In general, leborexan is effective in improving insomnia symptoms, but side effects such as daytime sleepiness, cognitive decline, headache, digestive discomfort, and abnormal mental status may still occur . The elderly, patients with hepatic insufficiency, combined with cardiovascular disease, or patients taking multiple central depressant drugs are high-risk groups. Through individualized dose adjustment, reasonable medication time, regular monitoring and lifestyle intervention, the efficacy of the drug can be maximized while reducing potential harm to health.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)